Immediate Impact

57 standout
Sub-graph 1 of 24

Citing Papers

Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
2024 Standout
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
2 intermediate papers

Works of R O'Laoide being referenced

Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial
2013
Outcome in Cystic Fibrosis Liver Disease
2010

Author Peers

Author Last Decade Papers Cites
R O'Laoide 151 165 75 91 26 427
Anat Ilivitzki 167 146 62 54 40 471
H Onitsuka 187 127 43 29 26 420
J Bernheim 95 90 34 54 35 460
Öznur Leman Konuş 153 70 49 28 18 425
A. Trusen 157 129 57 118 26 504
Craig Jm 118 82 46 27 22 392
M Koenigsberg 247 146 21 23 24 476
Ragna Vanslembrouck 205 78 61 265 21 490
Gamze Kılıçoğlu 284 95 92 26 46 487
Eoghan Laffan 180 174 70 25 24 478

All Works

Loading papers...

Rankless by CCL
2026